Cargando…
Towards a Systems Immunology Approach to Unravel Responses to Cancer Immunotherapy
Immunotherapy, particularly immune checkpoint blockade and chimeric antigen receptor (CAR)-T cells, holds a great promise against cancer. These treatments have markedly improved survival in solid as well as in hematologic tumors previously considered incurable. However, durable responses occur in a...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7649803/ https://www.ncbi.nlm.nih.gov/pubmed/33193392 http://dx.doi.org/10.3389/fimmu.2020.582744 |